33 results were returned
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
The capital markets experts based in London have advised on four placings which closed within the same week
International law firm Bird & Bird today expands its Corporate practice group with the appointment of James Baillieu as a partner in London.
The UK Financial Conduct Authority issues its first formal decision under the competition enforcement powers it was given in 2015. We look at the decision in more detail and its implication for market participants.
The excitement around the potential for the UK cannabis market – medicinal and nutritional – to continue opening up has really intensified in the first half of 2019.
The COVID-19 pandemic is increasingly having a significant impact on the economy and companies. In connec-tion with the crisis, managing directors of limited liability companies (GmbH) are confronted with a wide range ...
The London Stock Exchange has issued a disciplinary notice which highlights the importance of an AIM company needing to follow the guidance that has been given to it by its nominated adviser. We look at the implications ...
AIM companies must now disclose details of the recognised corporate governance code that it has adopted, how the company complies with this code or, where it departed from this code, an explanation of the reasons for ...
Yesterday (20 April 2020) the UK Government announced a scheme pledging £1 billion worth of support for start-ups struggling amidst the Coronavirus pandemic who are likely to be ineligible for the Government's emergency ...